Coriolus versicolor extracts: Relevance in cancer management

Current Oncology

Volumn 15, Issue 2, 2008, Pages 41-47

  Szeto, Maria ^a,b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b NONE   (Canada)

Author keywords

CAM; Mushroom extracts; Natural health products; PSK; PSP

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; CYTOKINE; FLUOROURACIL; INTERFERON; KRESTIN; MITOMYCIN C; PLACEBO; PLANT EXTRACT; POLYSACCHARIDE; POLYSACCHARIDE PEPTIDE; TEGAFUR; TRAMETES VERSICOLOR EXTRACT; UNCLASSIFIED DRUG;

ABNORMAL FECES; ADJUVANT THERAPY; ALTERNATIVE MEDICINE; ANOREXIA; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BLOOD TOXICITY; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER RECURRENCE; CANCER THERAPY; CLINICAL TRIAL; COLON CANCER; COLORECTAL CANCER; DIARRHEA; DISEASE FREE SURVIVAL; DRUG ELIMINATION; DRUG MECHANISM; DRUG SAFETY; DRY THROAT; ESOPHAGUS CANCER; FATIGUE; GASTROINTESTINAL TOXICITY; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; METASTASIS INHIBITION; MONOTHERAPY; NAIL COLOR DEFECT; NASOPHARYNX CANCER; NAUSEA; NONHUMAN; OVERALL SURVIVAL; PAIN; RECTUM CANCER; REVIEW; SIDE EFFECT; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; SWEATING; TRAMETES VERSICOLOR; TUMOR REGRESSION; VOMITING; XEROSTOMIA;

EID: 54349090641     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Pappas S, Perlman A. Complementary and alternative medicine. The importance of doctor-patient communication. Med Clin North Am 2002;86:1-10.
2. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-14.
3. Swarup AB, Barrett W, Jazich AR. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy. Am J Clin Oncol 2006;29:468-73.
4. Boon H, Stewart M, Kennard MA, et al. Use of complementary/ alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 2000;118:
5. Canada, Health Canada. Drugs health products; advisories, warnings & recalls - natural health products (Web resource]. Ottawa: Health Canada; February 2, 2006. [Available at: www.hc-sc.gc.ca/dhp-mps/advisories-avis/ natur/index_e.html; cited November 24, 2006]
6. de Lemos ML, John L, Nakashima L, O'Brien RK, Taylor SC. Advising cancer patients on natural health products structured approach. Ann Pharmacother 2004;38:1406-11.
7. Kidd PM. The use of mushroom glucans and protooglycans in cancer treatment. Altern Med Rev 2000;5:4-27.
8. Ng TB. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). Gen Pharmacol 1998;30:1-4.
9. Supreme Health Foods. Health food supplements: the difference between yunzhi and reishi [Web page]. Richmond Hill, ON: Supreme Health Foods; n.d. [Available at: www.supremehealthfoods.com/corpweb/ yunzhi-reishi.html; cited October 10, 20061]
10. American Cancer Society. Making treatment decisions, Coriolus versicolor (Web page]. Atlanta: American Cancer Society; June 1, 2005. [Available at: www.cancer.org/docroot/ETO/content/ ETO_5_3X_Coriolous_Versicolor.asp; cited October 3, 2006]
11. Memorial Sloan-Kettering Cancer Center. Cancer information: integrative medicine: about herbs, botanicals & other products: Coriolus versicolor [Web page]. New York: Memorial Sloan-Kettering Cancer Center; October 3, 2006. [Available at: www.mskcc.org/mskcc/html/ 69194.cfm; cited October 3, 2006]
12. Natural Medicines Comprehensive Database. Coriolus mushroom [Web page]. Stockton, CA: Therapeutic Research Faculty; December 1, 2006. [Available at: www.naturaldatabase.com (subscription required); cited December 1, 2006]
13. Chu KK, Ho SS, Chow AH. Coriolus versicolor a medicinal mushroom with promising immunotherapeutic values. J Clin Pharmacol 2002;42:976-84.
14. Ooi VE, Liu F. Inummomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 2000;7: 715-29.
15. Mitomi T, Tsuchiya S, Iijima. N, et al. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa). Dis Colon Rectum 1992;35: 123-30.
16. University of Texas M.D. Anderson Cancer Center. Complementary/ integrative medicine: herbal/plant therapies: Coriolus versicolor: detailed scientific review [Web page]. Houston, TX University of Texas M.D. Anderson Cancer Center; n.d. [Available at: www.mdanderson.org/ departments/CIMER/display.cfm?id=BF40CDD9- ED6B-11D4-810200508B603A14&method=displayFull&pn= 6EB86A59-EBD9-11D4-810100508B603A14; cited: October 3, 2006]
17. Fisher M, Yang LX Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res 2002;22:1737-54.
18. Kobayashi H, Matsunaga K, Oguchi Y. Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from Basidiomycetes: an overview. Cancer Epidemiol Biomarkers Prev 1995;4:275-81.
19. Salganik R. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 2001;20: 464S-75S.
20. Raez LE, Fein S, Podack ER. Lung cancer immunotherapy. Clin Med Res 2005;3:221-8.
21. Niimoto M, Hattori T, Tamada R, Sugimachi K, Inokuchi K, Ogawa N. Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years. Jpn J Surg 1988;18:681-6.
22. Hayakawa K, Mitsuhashi N, Saito Y, et al. Effect of Krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer. Anticancer Res 1993;13:1815-20.
23. Tsang KW, Lam CL, Yan C, et al. Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med 2003;97:618-24.
24. Canadian Cancer Society. About cancer; cancer statistics; lung cancer stats [Web page; Canada-wide statistics]. Toronto: Canadian Cancer Society; April 2006. [Available at: www.cancer.ca/ccs/internet/standard/ 0,2283,3172_14459∧ngId-en,00.html; cited: November 10, 2006]
25. Hernandez-Reif M, Ironson G, Field T, et al. Breast cancer patients have improved immune and neuroendocrine functions following massage therapy. J Psychosom Res 2004;57:45-52.
26. Cassileth BF, Deng G. Complementary and alternative therapies for cancer. Oncologist 2004;9:80-9.
27. Grunberg SM. Stage shift and complementary/alternative medicine. J Clin Oncol 2000;18:3455-6.
28. Richardson MA, White JD. Complementary/alternative medicine and cancer research: a national initiative. Cancer Pract 2000;8:45-8.
29. Lippert MC, McClain r, Boyd JC, Theodorescu D. Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer 1999;86:2642-8.
30. Correa-Velez I, Clavarino A, Eastwood H. Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis. J Palliat Med 2005;8:953-61.
31. Smith M, Boon H. Counseling cancer patients about herbal medicine. Patient Educ Couns 1999;38:109-20.
32. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997. JAMA 1998; 280:1569-75.
33. Frenkel MA, Borkan JM. An approach for integrating complementary-alternative medicine into primary care. Family Pract 2003;20:324-32.
34. American Dietetic Association (ADA). Advocacy & the profession; ADA practice papers; dietary supplements [Web page]. Chicago: ADA; 2005. [Available at: www.eatright.org/cps/rde/xchg/ada/hs.xs1/ advocacy_922_ENU_HTML.htm; cited: September 14, 2006]